Diana Vetter, Michal Cohen‐Naftaly, Augusto Villanueva, Youngmin A. Lee, Peri Kocabayoglu, Rebekka Hannivoort, Goutham Narla, Josep M. Llovet, Swan N. Thung, Scott L. Friedman – 26 April 2012 – KLF6‐SV1 (SV1), the major splice variant of KLF6, antagonizes the KLF6 tumor suppressor by an unknown mechanism. Decreased KLF6 expression in human hepatocellular carcinoma (HCC) correlates with increased mortality, but the contribution of increased SV1 is unknown.

Peter Ferenci – 26 April 2012 – Watch the interview with the authors

David L. Thomas – 26 April 2012 – Watch the interview with the authors

Amol S. Rangnekar, Robert J. Fontana – 26 April 2012 – Watch the interview with the authors

Anna S. Lok – 26 April 2012 – Watch the interview with the authors

Jordan J. Feld – 26 April 2012 – Watch the interview with the authors

Douglas L. Nguyen, Timothy R. Morgan – 26 April 2012 – Watch the interview with the authors

Syed‐Mohammed R. Jafri, Stuart C. Gordon – 26 April 2012 – Watch the interview with the authors

Amol S. Rangnekar, Robert J. Fontana – 26 April 2012 – Watch the interview with the authors

Edoardo G. Giannini, Simona Marenco, Giacomo Borgonovo, Vincenzo Savarino, Fabio Farinati, Paolo Del Poggio, Gian Ludovico Rapaccini, Maria Anna Di Nolfo, Luisa Benvegnù, Marco Zoli, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani, for the Italian Liver Cancer (ITA.LI.CA) group – 26 April 2012 – Alpha‐fetoprotein is a tumor marker that has been used for surveillance and diagnosis of hepatocellular carcinoma (HCC) in patients with cirrhosis. The prognostic capability of this marker in patients with HCC has not been clearly defined.